[HTML][HTML] Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta …
JKH Lee, GKL Lam, T Shin, SI Samson, DP Greenberg… - Vaccine, 2021 - Elsevier
Background Influenza vaccine efficacy/effectiveness can vary from season to season due in
part to the dominant circulating strains and antigenic matching. This study reviews the …
part to the dominant circulating strains and antigenic matching. This study reviews the …
Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis
JKH Lee, GKL Lam, T Shin, J Kim… - Expert review of …, 2018 - Taylor & Francis
Background: Influenza is responsible for a significant disease burden annually, especially in
older adults. This study reviews the relative vaccine efficacy or effectiveness (rVE) of high …
older adults. This study reviews the relative vaccine efficacy or effectiveness (rVE) of high …
Mortality associated with influenza and respiratory syncytial virus in the US, 1999-2018
CL Hansen, SS Chaves, C Demont… - JAMA Network …, 2022 - jamanetwork.com
Importance Respiratory syncytial virus (RSV) mortality estimates have not been updated
since 2009, and no study has assessed changes in influenza mortality after the 2009 …
since 2009, and no study has assessed changes in influenza mortality after the 2009 …
[HTML][HTML] Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices—United States, 2019–20 …
LA Grohskopf - MMWR. Recommendations and Reports, 2019 - cdc.gov
This report updates the 2018–19 recommendations of the Advisory Committee on
Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the …
Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the …
[HTML][HTML] Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices, United States, 2021–22 …
LA Grohskopf - MMWR. Recommendations and Reports, 2021 - cdc.gov
This report updates the 2020–21 recommendations of the Advisory Committee on
Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the …
Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the …
[HTML][HTML] Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices—United States, 2020–21 …
LA Grohskopf - MMWR. Recommendations and Reports, 2020 - cdc.gov
This report updates the 2019–20 recommendations of the Advisory Committee on
Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the …
Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the …
Relative effectiveness of cell-cultured and egg-based influenza vaccines among elderly persons in the United States, 2017–2018
HS Izurieta, Y Chillarige, J Kelman… - The Journal of …, 2019 - academic.oup.com
Background The low influenza vaccine effectiveness (VE) observed during the A (H3N2)-
dominated 2017–2018 season may be due to vaccine virus adaptation to growth in eggs …
dominated 2017–2018 season may be due to vaccine virus adaptation to growth in eggs …
Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster …
S Gravenstein, HE Davidson, M Taljaard… - The Lancet …, 2017 - thelancet.com
Background Immune responses to influenza vaccines decline with age, reducing clinical
effectiveness. We compared the effect of the more immunogenic high-dose trivalent …
effectiveness. We compared the effect of the more immunogenic high-dose trivalent …
Recombinant zoster vaccine (Shingrix): real-world effectiveness in the first 2 years post-licensure
Background Shingrix (recombinant zoster vaccine) was licensed to prevent herpes zoster,
dispensed as 2 doses given 2–6 months apart among adults aged≥ 50 years. Clinical trials …
dispensed as 2 doses given 2–6 months apart among adults aged≥ 50 years. Clinical trials …
Prevention of respiratory syncytial virus infection in healthy adults by a single immunization of Ad26. RSV. preF in a human challenge study
J Sadoff, E De Paepe, J DeVincenzo… - The Journal of …, 2022 - academic.oup.com
Background Respiratory syncytial virus (RSV) is a significant cause of severe lower
respiratory tract disease in children and older adults, but has no approved vaccine. This …
respiratory tract disease in children and older adults, but has no approved vaccine. This …